Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H E Johnsen
Chronic Myeloid Leukaemia With BCR–ABL Fusion Genes Located to Both Chromosomes 9, Cyclic Leukocytosis and Nodal T-Lymphoblastic Transformation – Durable Complete Remission Following Imatinib Therapy
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Use of Postmenopausal Hormone Replacement Therapy and Risk of Non-Hodgkin's Lymphoma: A Danish Population-Based Cohort Study
British Journal of Cancer
Cancer Research
Oncology
Related publications
Chronic Myeloid Leukemia With an E1a3 BCR-ABL Fusion Protein: Transformation to Lymphoid Blast Crisis
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
E19a2 BCR-ABL Fusion Transcript in Typical Chronic Myeloid Leukaemia: A Report of Two Cases
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Acute Myeloid Leukemia With BCR/ABL Fusion Chimera
Indian Journal of Hematology and Blood Transfusion
Hematology
Prognostic Significance of Micro RNA 150 Marker in BCR-ABL Positive Chronic Myeloid Leukaemia Patients on Imatinib Mesylate
International Journal of Contemporary Pediatrics
Anti-Rheumatic Agent Auranofin Induced Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib Through Both BCR/Abl-Dependent and -Independent Mechanisms
Oncotarget
Oncology
IPO-trimethylation of Histone H3-Lysine9associated With P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia
British Journal of Haematology
Hematology
Transcription-Mediated Amplification and Hybridisation Protection Assay to Determine BCR-ABL Transcript Levels in Patients With Chronic Myeloid Leukaemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Gynaecomastia in Men With Chronic Myeloid Leukaemia After Imatinib
The Lancet
Medicine
The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal
British Journal of Haematology
Hematology
